Supreme Court E-Library
Information At Your Fingertips


  View printer friendly version

(NAR) VOL. 1 NO.2 / APRIL - JUNE 1990

[ DDB BOARD REGULATION NO. 3, s. 1975, April 10, 1975 ]

EXCLUSION OF THE PRODUCT MERCODOL WITH IPECAC FROM THE LIST OF PROHIBITED DRUGS



Pursuant to the powers vested in the Dangerous Drugs Board under Section 36(a) of R.A. 6425, as amended, the following drug is hereby classified as an exempt preparation, the provisions of Board Regulation No. 5, series of 1974, notwithstanding.

Mercodol with Decapryn Cough Syrup with the following formulation and label indications:

Each teaspoonful (5 cc) contains:

Ipecac (total alkaloids                                  0.35 mg.

Mercodeinone (dihydrocodeinone

          bitartrate N.F.)                                     1.66 mg.

(Warning: May be habit forming)

Nethamine (etafedrine hydrochloride           16.60 mg.

Decapryn (doxylamine succinate)                 6.00 mg.

Sodium Citrate                                            200.00 mg.

Alcohol                                                          5%

Caution: "Contains Ipecac — Recommended dose must not be exceeded."

As herein classified, the above named preparation may be prescribed under ordinary prescriptions wherein the D-1(2) and S-2 licenses of the prescribing physicians, and the name and address of the patient should be indicated.

This Regulation shall take effect immediately.

Adopted: 10 April 1975

(SGD.) CLEMENTE S. GATMAITAN, M.D., M.P.H.
Chairman

© Supreme Court E-Library 2019
This website was designed and developed, and is maintained, by the E-Library Technical Staff in collaboration with the Management Information Systems Office.